VivoPharm Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
35
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
1
VivoPharm General Information
Description
Provider of proprietary preclinical oncology and immuno-oncology services intended to offer integrated service in different disease areas to the biotechnology and pharmaceutical industries. The company specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug (IND) filing, thereby enabling its clients to get treated in a better way in different disease areas.
Contact Information
Website
www.vivopharm.com.au(Operating Subsidiary)
Corporate Office
- Level 1, 4 Smart Road
- Suite S29
- Madbury, South Australia 5092
- Australia
Corporate Office
- Level 1, 4 Smart Road
- Suite S29
- Madbury, South Australia 5092
- Australia
VivoPharm Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
VivoPharm Comparisons
Industry
Financing
Details
VivoPharm Competitors (21)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Medelis | Private Equity-Backed | Thompson Station, TN | ||||
ABIONYX Pharma | Formerly VC-backed | Balma, France | ||||
Buffalo Biolabs | Corporation | Buffalo, NY | ||||
Accell Clinical Research | Corporation | Warrenton, VA | ||||
Celonic | Corporate Backed or Acquired | Basel, Switzerland |
VivoPharm Patents
VivoPharm Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2004901532-A0 | Tumour model | Inactive | 24-Mar-2004 | ||
AU-2005201291-A1 | Tumour model | Inactive | 24-Mar-2004 | ||
US-20050214220-A1 | Developing orthotopic animal models; quickly and reliably testing antitumor agent efficacy | Inactive | 24-Mar-2004 | A61K49/0008 |
VivoPharm Executive Team (7)
Name | Title | Board Seat |
---|---|---|
Ralf Brandt Ph.D | Chief Executive Officer & Managing Director | |
Sabine Brandt | Co-Founder & Executive Finance & HR Manager | |
Melanie Keller Ph.D | Vice President, Business Development and Division Head, Europe |
VivoPharm Signals
VivoPharm Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
VivoPharm Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
RMIT Drug Discovery Technologies | 11-Apr-2012 | Laboratory Services (Healthcare) |
VivoPharm FAQs
-
When was VivoPharm founded?
VivoPharm was founded in 2003.
-
Who is the founder of VivoPharm?
Ralf Brandt Ph.D and Sabine Brandt are the founders of VivoPharm.
-
Who is the CEO of VivoPharm?
Ralf Brandt Ph.D is the CEO of VivoPharm.
-
Where is VivoPharm headquartered?
VivoPharm is headquartered in Madbury, Australia.
-
What is the size of VivoPharm?
VivoPharm has 35 total employees.
-
What industry is VivoPharm in?
VivoPharm’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is VivoPharm a private or public company?
VivoPharm is a Private company.
-
What is the current valuation of VivoPharm?
The current valuation of VivoPharm is
. -
What is VivoPharm’s current revenue?
The current revenue for VivoPharm is
. -
How much funding has VivoPharm raised over time?
VivoPharm has raised $2.3M.
-
Who are VivoPharm’s investors?
Terra Rossa Capital, Vyant Bio, and Windsor Equities have invested in VivoPharm.
-
Who are VivoPharm’s competitors?
Medelis, ABIONYX Pharma, Buffalo Biolabs, Accell Clinical Research, and Celonic are some of the 21 competitors of VivoPharm.
-
When was VivoPharm acquired?
VivoPharm was acquired on 03-Nov-2022.
-
Who acquired VivoPharm?
VivoPharm was acquired by Reaction Biology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »